Canadian firm's implant controls glucose in diabetic pigs

07/12/2010 | Reuters

Diabetic pigs treated with Sernova's Cell Pouch System showed long-term normal glucose levels without experiencing adverse events, according to preclinical trials. The implantable device uses insulin-producing tissues, or islets, derived from the pancreas of the animals to enable the therapeutic cells to thrive and function in a natural environment.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX